P650: EFFECTIVENESS OF VENETOCLAX ACCORDING TO THE CHARACTERISTICS OF PATIENTS WITH CLL IN MONOTHERAPY AND COMBINATION WITH RITUXIMAB. INTERIM ANALYSIS OF REAL-LIFE DATA FROM VERON...

por Ysebaert, Loïc, Troussard, Xavier, Levy, Vincent, Le Calloch, Ronan, Guieze, Romain, Laribi, Kamel, Lepretre, Stephane, Sophie Michallet, Anne, Leblond, Véronique, Feugier, Pierre, Lahjibi, Elhem, Ramier, Julien, Delmer, Alain
Publicado 2023

Non-adherence to treatment with cytoreductive and/or antithrombotic drugs is frequent and associated with an increased risk of complications in patients with polycythemia vera or e...

por Le Calloch, Ronan, Lacut, Karine, Le Gall-Ianotto, Christelle, Nowak, Emmanuel, Abiven, Morgane, Tempescul, Adrian, Dalbies, Florence, Eveillard, Jean-Richard, Ugo, Valérie, Giraudier, Stéphane, Guillerm, Gaëlle, Lippert, Eric, Berthou, Christian, Ianotto, Jean-Christophe
Publicado 2018

Therapy-related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy

por Laribi, Kamel, Baugier de Materre, Alix, Ghez, David, Dartigeas, Caroline, Tomowiak, Cécile, Mahé, Béatrice, Micol, Jean-Baptiste, Merabet, Fatiha, Leprêtre, Stéphane, Herbaux, Charles, Ysebaert, Loïc, Le Calloch, Ronan, Willems, Lise, Voldoire, Maud, Roos-Weil, Damien, Bravetti, Clotilde, Touileb, Yamina, Davi, Frédéric, Nguyen-Khac, Florence, Maloum, Karim, Béné, Marie C.
Publicado 2022

Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group

por Aubrais, Raphaelle, Bouabdallah, Krimo, Chartier, Loic, Herbaux, Charles, Banos, Anne, Brice, Pauline, Sibon, David, Schiano, Jean Marc, Cluzeau, Thomas, Laribi, Kamel, Le Calloch, Ronan, Bellal, Mathieu, Delapierre, Baptiste, Daguindau, Nicolas, Amorim, Sandy, Agbetiafa, Kossi, Chauchet, Adrien, Besson, Caroline, Durot, Eric, Bonnet, Christophe, Fouillet, Ludovic, Bijou, Fontanet, Tournilhac, Olivier, Gaulard, Philippe, Parrens, Marie-Cécile, Damaj, Gandhi
Publicado 2022

Diagnosis and prognosis are supported by integrated assessment of next-generation sequencing in chronic myeloid malignancies. A real-life study

por Vantyghem, Sophie, Peterlin, Pierre, Thépot, Sylvain, Ménard, Audrey, Dubruille, Viviane, Debord, Camille, Guillaume, Thierry, Garnier, Alice, Le Bourgeois, Amandine, Wuilleme, Soraya, Godon, Catherine, Theisen, Olivier, Eveillard, Marion, Delaunay, Jacques, Maisonneuve, Hervé, Morineau, Nadine, Villemagne, Bruno, Vigouroux, Stéphane, Subiger, François, Lestang, Elsa, Loirat, Marion, Parcelier, Anne, Godmer, Pascal, Mercier, Mélanie, Trebouet, Adrien, Paz, Damien Luque, Le Calloch, Ronan, Le Clech, Lenaig, Bossard, Céline, Moreau, Anne, Ugo, Valérie, Hunault, Mathilde, Moreau, Philippe, Le Gouill, Steven, Chevallier, Patrice, Béné, Marie C., Le Bris, Yannick
Publicado 2020

Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: the IFM...

por Talbot, Alexis, Bobin, Arthur, Tabone, Léa, Lambert, Jérôme, Boccaccio, Catherine, Deal, Cécile, Petillon, Marie-Odile, Allangba, Olivier, Agape, Philippe, Arnautou, Pierre, Belkhir, Rakiba, Cailleres, Sylvie, Chaoui, Driss, Chrétien, Marie-Lorraine, Decaux, Olivier, Schulmann, Samantha, Frenzel, Laurent, Gastaud, Lauris, Huart, Antoine, Hulin, Cyrille, Karlin, Lionel, Laribi, Kamel, Le Calloch, Ronan, Lenain, Pascal, Macro, Margaret, Manier, Salomon, Montes, Lydia, Moreau, Stéphane, Moreau, Philippe, Morel, Véronique, Norwood, James, Piocelle, Frédérique Orsini, Perrot, Aurore, Pica, Gian Matteo, Rey, Philippe, Schmitt, Anna, Stoppa, Anne-Marie, Tiab, Mourad, Touzeau, Cyrille, Vidal, Valérie, Vignon, Marguerite, Vincent, Laure, Van De Wyngaert, Zoé, Zarnitsky, Charles, Kerbouche, Naima, Paka, Prani, Leleu, Xavier, Arnulf, Bertrand, Avet-Loiseau, Hervé
Publicado 2023